Strategic workshops on cancer nanotechnology

Larry A. Nagahara; Jerry S.H. Lee; Linda K. Molnar; Nicholas J. Panaro; Dorothy Farrell; Krzysztof Ptak; Joseph Alper; Piotr Grodzinski

doi:10.1158/0008-5472.CAN-09-3716

Strategic workshops on cancer nanotechnology

Larry A. Nagahara, Jerry S.H. Lee, Linda K. Molnar, Nicholas J. Panaro, Dorothy Farrell, Krzysztof Ptak, Joseph Alper, Piotr Grodzinski^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation.

Original language	English
Pages (from-to)	4265-4268
Number of pages	4
Journal	Cancer Research
Volume	70
Issue number	11
DOIs	https://doi.org/10.1158/0008-5472.CAN-09-3716
State	Published - 1 Jun 2010
Externally published	Yes

Access to Document

10.1158/0008-5472.CAN-09-3716

Cite this

@article{bb47190b744746f88030bef6424bed4d,

title = "Strategic workshops on cancer nanotechnology",

abstract = "Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation.",

author = "Nagahara, {Larry A.} and Lee, {Jerry S.H.} and Molnar, {Linda K.} and Panaro, {Nicholas J.} and Dorothy Farrell and Krzysztof Ptak and Joseph Alper and Piotr Grodzinski",

year = "2010",

month = jun,

day = "1",

doi = "10.1158/0008-5472.CAN-09-3716",

language = "English",

volume = "70",

pages = "4265--4268",

journal = "Cancer Research",

issn = "0008-5472",

number = "11",

}

TY - JOUR

T1 - Strategic workshops on cancer nanotechnology

AU - Nagahara, Larry A.

AU - Lee, Jerry S.H.

AU - Molnar, Linda K.

AU - Panaro, Nicholas J.

AU - Farrell, Dorothy

AU - Ptak, Krzysztof

AU - Alper, Joseph

AU - Grodzinski, Piotr

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation.

AB - Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation.

UR - http://www.scopus.com/inward/record.url?scp=77953161756&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-3716

DO - 10.1158/0008-5472.CAN-09-3716

M3 - Article

C2 - 20460532

AN - SCOPUS:77953161756

SN - 0008-5472

VL - 70

SP - 4265

EP - 4268

JO - Cancer Research

JF - Cancer Research

IS - 11

ER -

Strategic workshops on cancer nanotechnology

Abstract

Access to Document

Fingerprint

Cite this